SAA1 and endothelial dysfunction: In the context of endothelial dysfunction (an early event in the process of atherogenesis), the cyclic nitroxide 4-methoxy-tempo (4-MetT) inhibits the SAA-mediated activation of cultured aortic endothelial cells, subsequently decreasing the adhesion of immune cells [31], suggestive of an anti-atherosclerotic action.